000304275 001__ 304275
000304275 005__ 20251023095933.0
000304275 0247_ $$2doi$$a10.1111/ddg.15868
000304275 0247_ $$2pmid$$apmid:40884115
000304275 0247_ $$2ISSN$$a1610-0379
000304275 0247_ $$2ISSN$$a0301-0481
000304275 0247_ $$2ISSN$$a0303-8173
000304275 0247_ $$2ISSN$$a1439-0353
000304275 0247_ $$2ISSN$$a1563-2571
000304275 0247_ $$2ISSN$$a1610-0387
000304275 037__ $$aDKFZ-2025-01816
000304275 041__ $$aEnglish
000304275 082__ $$a610
000304275 1001_ $$aBurmann, Sven-Niklas$$b0
000304275 245__ $$aLeukemia cutis with concomitant acrodermatitis chronica atrophicans and chronic B-cell lymphocytic leukemia: complete clearance under doxycycline therapy.
000304275 260__ $$aBerlin$$bWiley-Blackwell$$c2025
000304275 3367_ $$2DRIVER$$aarticle
000304275 3367_ $$2DataCite$$aOutput Types/Journal article
000304275 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1761206351_2347371$$xLetter
000304275 3367_ $$2BibTeX$$aARTICLE
000304275 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000304275 3367_ $$00$$2EndNote$$aJournal Article
000304275 500__ $$aepub / Clinical letter
000304275 536__ $$0G:(DE-HGF)POF4-899$$a899 - ohne Topic (POF4-899)$$cPOF4-899$$fPOF IV$$x0
000304275 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000304275 650_7 $$2Other$$aAcrodermatitis chronica atrophicans
000304275 650_7 $$2Other$$aborreliosis
000304275 650_7 $$2Other$$achronic B‐cell lymphocytic leukemia
000304275 650_7 $$2Other$$adoxycycline
000304275 650_7 $$2Other$$aleukemia cutis
000304275 650_7 $$2Other$$alymphoproliferative diseases
000304275 7001_ $$00000-0001-7862-3695$$aGambichler, Thilo$$b1
000304275 7001_ $$0P:(DE-He78)7bf2f090fe39a6cd6f0bccf5ea2d4fb3$$aBecker, Jürgen C$$b2$$udkfz
000304275 7001_ $$aOellig, Frank$$b3
000304275 7001_ $$00000-0003-2275-499X$$aKreuter, Alexander$$b4
000304275 7001_ $$aWehry, Ulrich Peter$$b5
000304275 773__ $$0PERI:(DE-600)2099463-1$$a10.1111/ddg.15868$$gp. ddg.15868$$pnn$$tJournal der Deutschen Dermatologischen Gesellschaft$$vnn$$x1610-0379$$y2025
000304275 909CO $$ooai:inrepo02.dkfz.de:304275$$pVDB
000304275 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7bf2f090fe39a6cd6f0bccf5ea2d4fb3$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000304275 9131_ $$0G:(DE-HGF)POF4-899$$1G:(DE-HGF)POF4-890$$2G:(DE-HGF)POF4-800$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000304275 9141_ $$y2025
000304275 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2024-12-19$$wger
000304275 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-19
000304275 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-19
000304275 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-19
000304275 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-19
000304275 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-19
000304275 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-19
000304275 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-19
000304275 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-19
000304275 9201_ $$0I:(DE-He78)ED01-20160331$$kED01$$lDKTK Koordinierungsstelle Essen/Düsseldorf$$x0
000304275 980__ $$ajournal
000304275 980__ $$aVDB
000304275 980__ $$aI:(DE-He78)ED01-20160331
000304275 980__ $$aUNRESTRICTED